President Trump’s EO to lower drug prices is the beginning of a long process, says Jeff Jonas

Jeff Jonas, Gabelli Funds portfolio manager, joins CNBC’s ‘Power Lunch’ to discuss reactions to President Trump’s executive order to lower drug prices, the impact to pharma companies, and more.